Table 1

Mean Zones of Inhibition (diameter mm including well (8.2 mm))

Concentration

50% v/v

25% v/v

12.5% v/v

6.3% v/v


Isolates

Ulmo

Manuka

Ulmo

Manuka

Ulmo

Manuka

Ulmo

Manuka


MRSA ATCC 43300

30 (1.7)

24 (1.5)

26 (0.6)

19 (2.1)

18 (0.6)

13 (1.0)

10 (0.6)

-

MRSA 0791*

34 (1.5)

23 (1.2)

29 (1.7)

17 (1.7)

22 (2.1)

-

14 (2.5)

-

MRSA 28965*

24 (1.0)

17 (1.7)

19 (1.5)

15 (2.0)

-

-

-

-

MRSA 01322*

28 (5.8)

22 (1.0)

23 (4.2)

18 (0.6)

17 (2.9)

-

11 (2.0)

-

MRSA 0745*

23 (2.7)

20 (1.7)

19 (2.1)

13 (1.7)

11 (2.7)

-

-

-

P. aeruginosa ATCC 27853

14 (2.3)

16 (7.8)

11 (1.0)

14 (6.9)

-

-

-

-

E. coli ATCC 35218

14 (1.5)

15 (2.5)

11 (1.7)

12 (2.9)

-

-

-

-


* Clinical isolates

The antimicrobial activity of Ulmo honey in comparison to manuka honey against five MRSA strains, E. coli and Pseudomonas aeruginosa, assessed by agar well diffusion assay (n = 3). Where no value is given, no zone of inhibition was observed.

Standard deviation values (±) are in brackets

Sherlock et al. BMC Complementary and Alternative Medicine 2010 10:47   doi:10.1186/1472-6882-10-47

Open Data